Successful off-label use of cinacalcet HCI after standard therapy failure in a young man with pseudohypoparathyroidism Type 1b and vitamin D intoxication sequelae

Clinical Nephrology

Volumn 70, Issue 5, 2008, Pages 439-444

  Koch, M ^a,b   Kohnle, M ^a  

^a and Metabolic Diseases   (Germany)

^b NONE   (Germany)

Author keywords

Calcium; Cinacalcet HCI; Parathormone; Pseudohypoparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMLODIPINE; ATENOLOL; CALCITRIOL; CALCIUM; CINACALCET; COLECALCIFEROL; CREATININE; DIHYDROTACHYSTEROL; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; RAMIPRIL; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CONCENTRATION LOSS; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECHOGRAPHY; FATIGUE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOCALCEMIA; KIDNEY CALCIFICATION; MALE; OFF LABEL DRUG USE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POLYDIPSIA; POLYURIA; PSEUDOHYPOPARATHYROIDISM; RECOMMENDED DRUG DOSE; TETANIC SPASM; VITAMIN D INTOXICATION;

EID: 56749131128     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70439     Document Type: Article

References (10)

1. Albright F, Forbes AP, Henneman PH. Pseudohypoparathyroidism. Am Physicians. 1952; 65: 337-350.
2. Barman Balfour JA, Scott LJ. Cinacalcet hydrochloride. Drugs. 2005; 65: 271-281.
3. 3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism. Clin Calcium. 2007; 17: 1255-1261.
4. Kind HP, Handysides A, Kooh SW, Fraser D. Vitamin D therapy in hypoparathyroidism and pseudohypoparathyroidism: weight-related dosages for initiation of therapy and maintenance therapy. J Pediatr. 1977; 91: 1006-1010.
5. Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metab. 2006; 50: 664-673.
6. Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial. 2007; 11: 202-209.
7. Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone. Bone. 2004; 35: 224-230.
8. Schneider AB, Sherwood LM. Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders. Metabolism. 1975; 24: 871-898.
9. Stogmann W, Fischer JA. Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D. Am J Med. 1975; 59: 140-144.
10. Vlaeminck-Guillem V, Wemeau JL. Pseudohypoparathyroidism and the concept of hormonal resistance. Diagnosis, classification and therapy. Presse Med. 1999; 28: 1434-1437.